Computational Simulations Identify Pyrrolidine-2,3-Dione Derivatives as Novel Inhibitors of Cdk5/p25 Complex to Attenuate Alzheimer's Pathologyopen access
- Authors
- Zeb, Amir; Kim, Donghwan; Alam, Sayed Ibrar; Son, Minky; Kumar, Raj; Rampogu, Shailima; Parameswaran, Saravanan; Shelake, Rahul Mahadev; Rana, Rabia Mukhtar; Parate, Shraddha; Kim, Jae-Yean; Lee, Keun Woo
- Issue Date
- May-2019
- Publisher
- MDPI
- Keywords
- Cdk5; p25 inhibition; molecular dynamics simulation; pharmacophore modeling; pyrrolidine-2; 3-dione; inhibition of tau-protein phosphorylation; Alzheimer' s pathology
- Citation
- JOURNAL OF CLINICAL MEDICINE, v.8, no.5
- Indexed
- SCIE
SCOPUS
- Journal Title
- JOURNAL OF CLINICAL MEDICINE
- Volume
- 8
- Number
- 5
- URI
- https://scholarworks.bwise.kr/gnu/handle/sw.gnu/9179
- DOI
- 10.3390/jcm8050746
- ISSN
- 2077-0383
- Abstract
- Mechanistically, neurotoxic insults provoke Ca2+-mediated calpain activation, which cleaves the cytoplasmic region of membrane-embedded p35 and produces its truncated form p25. Upon physical interaction, cyclin-dependent kinase 5 (Cdk5) and p25 forms hyperactivated Cdk5/p25 complex and causes severe neuropathological aberrations including hyperphosphorylated tau-mediated neurofibrillary tangles formation, Alzheimer's symptoms, and neuronal death. Therefore, the inhibition of Cdk5/p25 complex may relieve p-tau-mediated Alzheimer's pathology. Herein, computational simulations have identified pyrrolidine-2,3-dione derivatives as novel inhibitors of Cdk5/p25 complex. A ligand-based pharmacophore was designed and employed as 3D query to retrieve drug-like molecules from chemical databases. By molecular docking, drug-like molecules obtaining dock score > 67.67 (Goldcore of the reference compound) were identified. Molecular dynamics simulation and binding free energy calculation retrieved four pyrrolidine-2,3-dione derivatives as novel candidate inhibitors of Cdk5/p25. The root means square deviation of Cdk5/p25 in complex with candidate inhibitors obtained an average value of similar to 2.15 angstrom during the 30 ns simulation period. Molecular interactions analysis suggested that each inhibitor occupied the ATP-binding site of Cdk5/p25 and formed stable interactions. Finally, the binding free energy estimation suggested that each inhibitor had lowest binding energy than the reference compound (-113.10 kJ/mol) to recapitulate their strong binding with Cdk5/p25. Overall, these inhibitors could mitigate tau-mediated Alzheimer's phenotype.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - ETC > Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.